Get the latest news on Titan Medical Inc stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on TMDIF performance

Latest Titan Medical Inc Stock News | OTC:TMDIF | Benzinga

Titan Medical Inc

Press Releases

Independent Proxy Advisor, Institutional Shareholder Services ("ISS"), Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi

Titan Announces Conavi Medical to Present Overview at Titan Q&A Session

Proxy Advisor Glass, Lewis & Co., Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi

Proxy Deadline Thursday September 26, 2024

Conavi Medical Shareholders Approve the Proposed Amalgamation Between Titan and Conavi

Titan Medical begins process to move to the TSX Venture Exchange

Titan Reports Voting Results from 2023 Annual General and Special Meeting

Titan Announces Resignations of Directors

Titan Announces the Closing of Conavi's Private Placement of Subscription Receipts and Provides Update on the Transaction

News

Conavi Medical Corp. (formerly "Titan Medical Inc.") Completes Business Combination

TMDIF

TSX:TMD

Titan Medical

Titan Medical Inc. (&quot;Titan&quot; or the &quot;Company&quot;) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TMD#TSX">TMD</a>, OTC:<a class="ticker" href="https://www.benzinga.com/stock/TMDIF#OTC">TMDIF</a>) announced today that the Company has entered into a license agreement (&quot;Agreement&quot;) with Intuitive Surgical, Inc. (&quot;Intuitive&quot;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery (&quot;RAS&quot;), for an upfront payment of US$7.5 million in respect of certain intellectual property (&quot;IP&quot;) of Titan. 
&nbsp;

Under the Agreement, Titan has granted Intuitive a non-exclusive license to all of Titan&#39;s IP, with the exception of the IP that is exclusively licensed to another party under a June 2020 license agreement. Titan retains ownership of the licensed IP, along with the associated rights including the right to continue to develop and commercialize the technologies covered by the licensed IP and the right to license the IP to other third parties.

Biotech

Contracts

General

ISRG

'Titan Medical Signs License Agreement With Intuitive Surgical; For An Upfront Payment Of $7.5M In Respect Of Certain Intellectual Property Of Titan'

Comments

Titan Medical Inc Stock News

News

Latest Titan Medical Inc Stock News | OTC:TMDIF | Benzinga

Friday, May 26, 2023

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga